Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure have?
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure has 188 citations in the OpenAlex counts ScholarIQ stores.
When was Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure published?
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure has 2019 year in the ScholarIQ index.
What is the open-access status of Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure?
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure has hybrid oa status in the ScholarIQ index.
What is the DOI of Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure?
The DOI for Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure is on the source record.
What is the PMID of Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure?
The PMID for Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure is on the source record.
What is the OpenAlex record for Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure?
The OpenAlex for Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure is on the source record.